Physician profile
Kristin Williams
NPI 1316950108
$889.07
in general payments reported to CMS, 2019-2025
18 companies · $52.52 in 2025
The $52.52 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.68 · 2020: $31.65 · 2021: $96.10 · 2022: $73.82 · 2023: $314 · 2024: $252 · 2025: $52.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $618.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $159.99 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Pfizer INC. | $111.38 | 2019-2024 | |
| Shield Therapeutics INC | $105.43 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.10 | 2020-2023 | |
| Coopersurgical, INC. | $63.79 | 2022-2023 | Endosee |
| Mayne Pharma Commercial LLC | $61.36 | 2023 | |
| Sumitomo Pharma America, INC. | $55.00 | 2023-2025 | Myfembree, Gemtesa |
| Organon LLC | $41.04 | 2022-2023 | Nexplanon |
| Exeltis, USA INC. | $37.01 | 2023-2024 | Slynd |
| Astellas Pharma US INC | $34.43 | 2025 | Veozah |
| Exact Sciences Corporation | $29.54 | 2024 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $27.82 | 2019-2021 | |
| Avion Pharmaceuticals | $25.01 | 2023 | Balcoltra |
| Daiichi Sankyo INC. | $17.25 | 2021 | |
| Amag Pharmaceuticals, INC. | $14.55 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $14.02 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Smith+Nephew, INC. | $13.41 | 2020 | |
| Therapeuticsmd, INC. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.